Zurich Cantonal Bank
ADMS

Zurich Cantonal Bank’s Adamas Pharmaceuticals ADMS Stock Holding History

Zurich Cantonal Bank’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,156
Closed -$8K – 2642
2019
Q1 		$8K Sell
1,156
-1,373
-54% -$12.3K ﹤0.01% 2535
2018
Q4 		$22K Hold
2,529
– – ﹤0.01% 2426
2018
Q3 		$51K Hold
2,529
– – ﹤0.01% 2152
2018
Q2 		$65K Buy
+2,529
New +$70K ﹤0.01% 1956

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Zurich Cantonal Bank's ADMS Position: Q2 2019 in Review

Zurich Cantonal Bank sold out of Adamas Pharmaceuticals (ADMS) in Q2 2019, closing a stake of 1,156 shares — an estimated $8K sold.

Zurich Cantonal Bank first reported a position in ADMS in Q2 2018 and held it in 4 quarters. The position peaked at $65K in Q2 2018. 78 funds tracked by Wall St. Rank hold ADMS as of Q2 2019.

  • Zurich Cantonal Bank reported no remaining Adamas Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,156 Adamas Pharmaceuticals shares in Q2 2019, an estimated $8K.
  • Zurich Cantonal Bank first reported a position in Adamas Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Zurich Cantonal Bank's Adamas Pharmaceuticals position peaked at $65K in Q2 2018.
  • 78 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2019.

Based on Zurich Cantonal Bank's 13F filing for Q2 2019, filed 30 Jul 2019.